The global Medications for Canine Atopic Dermatitis market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
Oral Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Medications for Canine Atopic Dermatitis include GlenHaven, DermaPet, DVM Pharmaceuticals, Virbac, Enzo Life Sciences, Inc., Pfizer Animal Health, Novartis Animal Health, Inc., Eli Lilly and Company and Perrigo, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Medications for Canine Atopic Dermatitis, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Medications for Canine Atopic Dermatitis. This report contains market size and forecasts of Medications for Canine Atopic Dermatitis in global, including the following market information:
Global Medications for Canine Atopic Dermatitis Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Medications for Canine Atopic Dermatitis Market Sales, 2019-2024, 2025-2030, (K Units)
Global top five Medications for Canine Atopic Dermatitis companies in 2023 (%)
We surveyed the Medications for Canine Atopic Dermatitis manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medications for Canine Atopic Dermatitis Market, by Type, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Medications for Canine Atopic Dermatitis Market Segment Percentages, by Type, 2023 (%)
Oral
External Use
Injection
Global Medications for Canine Atopic Dermatitis Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Medications for Canine Atopic Dermatitis Market Segment Percentages, by Application, 2023 (%)
Veterinary Hospital
Veterinary Clinic
Global Medications for Canine Atopic Dermatitis Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (K Units)
Global Medications for Canine Atopic Dermatitis Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Medications for Canine Atopic Dermatitis revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Medications for Canine Atopic Dermatitis revenues share in global market, 2023 (%)
Key companies Medications for Canine Atopic Dermatitis sales in global market, 2019-2024 (Estimated), (K Units)
Key companies Medications for Canine Atopic Dermatitis sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
GlenHaven
DermaPet
DVM Pharmaceuticals
Virbac
Enzo Life Sciences, Inc.
Pfizer Animal Health
Novartis Animal Health, Inc.
Eli Lilly and Company
Perrigo
Merck & Company
Zoetis Inc.
Toray Industries, Inc
Bayer Animal Health
Putney, Inc.
Dechra
Elanco
Kindred Biosciences
Nippon Zenyaku Kogyo Co., Ltd.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Medications for Canine Atopic Dermatitis, market overview.
Chapter 2: Global Medications for Canine Atopic Dermatitis market size in revenue and volume.
Chapter 3: Detailed analysis of Medications for Canine Atopic Dermatitis manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Medications for Canine Atopic Dermatitis in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Medications for Canine Atopic Dermatitis capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Medications for Canine Atopic Dermatitis Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Medications for Canine Atopic Dermatitis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Medications for Canine Atopic Dermatitis Overall Market Size
2.1 Global Medications for Canine Atopic Dermatitis Market Size: 2023 VS 2030
2.2 Global Medications for Canine Atopic Dermatitis Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Medications for Canine Atopic Dermatitis Sales: 2019-2030
3 Company Landscape
3.1 Top Medications for Canine Atopic Dermatitis Players in Global Market
3.2 Top Global Medications for Canine Atopic Dermatitis Companies Ranked by Revenue
3.3 Global Medications for Canine Atopic Dermatitis Revenue by Companies
3.4 Global Medications for Canine Atopic Dermatitis Sales by Companies
3.5 Global Medications for Canine Atopic Dermatitis Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Medications for Canine Atopic Dermatitis Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Medications for Canine Atopic Dermatitis Product Type
3.8 Tier 1, Tier 2 and Tier 3 Medications for Canine Atopic Dermatitis Players in Global Market
3.8.1 List of Global Tier 1 Medications for Canine Atopic Dermatitis Companies
3.8.2 List of Global Tier 2 and Tier 3 Medications for Canine Atopic Dermatitis Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Medications for Canine Atopic Dermatitis Market Size Markets, 2023 & 2030
4.1.2 Oral
4.1.3 External Use
4.1.4 Injection
4.2 By Type - Global Medications for Canine Atopic Dermatitis Revenue & Forecasts
4.2.1 By Type - Global Medications for Canine Atopic Dermatitis Revenue, 2019-2024
4.2.2 By Type - Global Medications for Canine Atopic Dermatitis Revenue, 2025-2030
4.2.3 By Type - Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
4.3 By Type - Global Medications for Canine Atopic Dermatitis Sales & Forecasts
4.3.1 By Type - Global Medications for Canine Atopic Dermatitis Sales, 2019-2024
4.3.2 By Type - Global Medications for Canine Atopic Dermatitis Sales, 2025-2030
4.3.3 By Type - Global Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
4.4 By Type - Global Medications for Canine Atopic Dermatitis Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Medications for Canine Atopic Dermatitis Market Size, 2023 & 2030
5.1.2 Veterinary Hospital
5.1.3 Veterinary Clinic
5.2 By Application - Global Medications for Canine Atopic Dermatitis Revenue & Forecasts
5.2.1 By Application - Global Medications for Canine Atopic Dermatitis Revenue, 2019-2024
5.2.2 By Application - Global Medications for Canine Atopic Dermatitis Revenue, 2025-2030
5.2.3 By Application - Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
5.3 By Application - Global Medications for Canine Atopic Dermatitis Sales & Forecasts
5.3.1 By Application - Global Medications for Canine Atopic Dermatitis Sales, 2019-2024
5.3.2 By Application - Global Medications for Canine Atopic Dermatitis Sales, 2025-2030
5.3.3 By Application - Global Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
5.4 By Application - Global Medications for Canine Atopic Dermatitis Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Medications for Canine Atopic Dermatitis Market Size, 2023 & 2030
6.2 By Region - Global Medications for Canine Atopic Dermatitis Revenue & Forecasts
6.2.1 By Region - Global Medications for Canine Atopic Dermatitis Revenue, 2019-2024
6.2.2 By Region - Global Medications for Canine Atopic Dermatitis Revenue, 2025-2030
6.2.3 By Region - Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
6.3 By Region - Global Medications for Canine Atopic Dermatitis Sales & Forecasts
6.3.1 By Region - Global Medications for Canine Atopic Dermatitis Sales, 2019-2024
6.3.2 By Region - Global Medications for Canine Atopic Dermatitis Sales, 2025-2030
6.3.3 By Region - Global Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Medications for Canine Atopic Dermatitis Revenue, 2019-2030
6.4.2 By Country - North America Medications for Canine Atopic Dermatitis Sales, 2019-2030
6.4.3 US Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.4.4 Canada Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.4.5 Mexico Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Medications for Canine Atopic Dermatitis Revenue, 2019-2030
6.5.2 By Country - Europe Medications for Canine Atopic Dermatitis Sales, 2019-2030
6.5.3 Germany Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.5.4 France Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.5.5 U.K. Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.5.6 Italy Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.5.7 Russia Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.5.8 Nordic Countries Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.5.9 Benelux Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Medications for Canine Atopic Dermatitis Revenue, 2019-2030
6.6.2 By Region - Asia Medications for Canine Atopic Dermatitis Sales, 2019-2030
6.6.3 China Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.6.4 Japan Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.6.5 South Korea Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.6.6 Southeast Asia Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.6.7 India Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Medications for Canine Atopic Dermatitis Revenue, 2019-2030
6.7.2 By Country - South America Medications for Canine Atopic Dermatitis Sales, 2019-2030
6.7.3 Brazil Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.7.4 Argentina Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Medications for Canine Atopic Dermatitis Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Medications for Canine Atopic Dermatitis Sales, 2019-2030
6.8.3 Turkey Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.8.4 Israel Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.8.5 Saudi Arabia Medications for Canine Atopic Dermatitis Market Size, 2019-2030
6.8.6 UAE Medications for Canine Atopic Dermatitis Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 GlenHaven
7.1.1 GlenHaven Company Summary
7.1.2 GlenHaven Business Overview
7.1.3 GlenHaven Medications for Canine Atopic Dermatitis Major Product Offerings
7.1.4 GlenHaven Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.1.5 GlenHaven Key News & Latest Developments
7.2 DermaPet
7.2.1 DermaPet Company Summary
7.2.2 DermaPet Business Overview
7.2.3 DermaPet Medications for Canine Atopic Dermatitis Major Product Offerings
7.2.4 DermaPet Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.2.5 DermaPet Key News & Latest Developments
7.3 DVM Pharmaceuticals
7.3.1 DVM Pharmaceuticals Company Summary
7.3.2 DVM Pharmaceuticals Business Overview
7.3.3 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Major Product Offerings
7.3.4 DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.3.5 DVM Pharmaceuticals Key News & Latest Developments
7.4 Virbac
7.4.1 Virbac Company Summary
7.4.2 Virbac Business Overview
7.4.3 Virbac Medications for Canine Atopic Dermatitis Major Product Offerings
7.4.4 Virbac Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.4.5 Virbac Key News & Latest Developments
7.5 Enzo Life Sciences, Inc.
7.5.1 Enzo Life Sciences, Inc. Company Summary
7.5.2 Enzo Life Sciences, Inc. Business Overview
7.5.3 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Major Product Offerings
7.5.4 Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.5.5 Enzo Life Sciences, Inc. Key News & Latest Developments
7.6 Pfizer Animal Health
7.6.1 Pfizer Animal Health Company Summary
7.6.2 Pfizer Animal Health Business Overview
7.6.3 Pfizer Animal Health Medications for Canine Atopic Dermatitis Major Product Offerings
7.6.4 Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.6.5 Pfizer Animal Health Key News & Latest Developments
7.7 Novartis Animal Health, Inc.
7.7.1 Novartis Animal Health, Inc. Company Summary
7.7.2 Novartis Animal Health, Inc. Business Overview
7.7.3 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Major Product Offerings
7.7.4 Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.7.5 Novartis Animal Health, Inc. Key News & Latest Developments
7.8 Eli Lilly and Company
7.8.1 Eli Lilly and Company Company Summary
7.8.2 Eli Lilly and Company Business Overview
7.8.3 Eli Lilly and Company Medications for Canine Atopic Dermatitis Major Product Offerings
7.8.4 Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.8.5 Eli Lilly and Company Key News & Latest Developments
7.9 Perrigo
7.9.1 Perrigo Company Summary
7.9.2 Perrigo Business Overview
7.9.3 Perrigo Medications for Canine Atopic Dermatitis Major Product Offerings
7.9.4 Perrigo Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.9.5 Perrigo Key News & Latest Developments
7.10 Merck & Company
7.10.1 Merck & Company Company Summary
7.10.2 Merck & Company Business Overview
7.10.3 Merck & Company Medications for Canine Atopic Dermatitis Major Product Offerings
7.10.4 Merck & Company Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.10.5 Merck & Company Key News & Latest Developments
7.11 Zoetis Inc.
7.11.1 Zoetis Inc. Company Summary
7.11.2 Zoetis Inc. Medications for Canine Atopic Dermatitis Business Overview
7.11.3 Zoetis Inc. Medications for Canine Atopic Dermatitis Major Product Offerings
7.11.4 Zoetis Inc. Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.11.5 Zoetis Inc. Key News & Latest Developments
7.12 Toray Industries, Inc
7.12.1 Toray Industries, Inc Company Summary
7.12.2 Toray Industries, Inc Medications for Canine Atopic Dermatitis Business Overview
7.12.3 Toray Industries, Inc Medications for Canine Atopic Dermatitis Major Product Offerings
7.12.4 Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.12.5 Toray Industries, Inc Key News & Latest Developments
7.13 Bayer Animal Health
7.13.1 Bayer Animal Health Company Summary
7.13.2 Bayer Animal Health Medications for Canine Atopic Dermatitis Business Overview
7.13.3 Bayer Animal Health Medications for Canine Atopic Dermatitis Major Product Offerings
7.13.4 Bayer Animal Health Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.13.5 Bayer Animal Health Key News & Latest Developments
7.14 Putney, Inc.
7.14.1 Putney, Inc. Company Summary
7.14.2 Putney, Inc. Business Overview
7.14.3 Putney, Inc. Medications for Canine Atopic Dermatitis Major Product Offerings
7.14.4 Putney, Inc. Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.14.5 Putney, Inc. Key News & Latest Developments
7.15 Dechra
7.15.1 Dechra Company Summary
7.15.2 Dechra Business Overview
7.15.3 Dechra Medications for Canine Atopic Dermatitis Major Product Offerings
7.15.4 Dechra Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.15.5 Dechra Key News & Latest Developments
7.16 Elanco
7.16.1 Elanco Company Summary
7.16.2 Elanco Business Overview
7.16.3 Elanco Medications for Canine Atopic Dermatitis Major Product Offerings
7.16.4 Elanco Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.16.5 Elanco Key News & Latest Developments
7.17 Kindred Biosciences
7.17.1 Kindred Biosciences Company Summary
7.17.2 Kindred Biosciences Business Overview
7.17.3 Kindred Biosciences Medications for Canine Atopic Dermatitis Major Product Offerings
7.17.4 Kindred Biosciences Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.17.5 Kindred Biosciences Key News & Latest Developments
7.18 Nippon Zenyaku Kogyo Co., Ltd.
7.18.1 Nippon Zenyaku Kogyo Co., Ltd. Company Summary
7.18.2 Nippon Zenyaku Kogyo Co., Ltd. Business Overview
7.18.3 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Major Product Offerings
7.18.4 Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales and Revenue in Global (2019-2024)
7.18.5 Nippon Zenyaku Kogyo Co., Ltd. Key News & Latest Developments
8 Global Medications for Canine Atopic Dermatitis Production Capacity, Analysis
8.1 Global Medications for Canine Atopic Dermatitis Production Capacity, 2019-2030
8.2 Medications for Canine Atopic Dermatitis Production Capacity of Key Manufacturers in Global Market
8.3 Global Medications for Canine Atopic Dermatitis Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Medications for Canine Atopic Dermatitis Supply Chain Analysis
10.1 Medications for Canine Atopic Dermatitis Industry Value Chain
10.2 Medications for Canine Atopic Dermatitis Upstream Market
10.3 Medications for Canine Atopic Dermatitis Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Medications for Canine Atopic Dermatitis Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Medications for Canine Atopic Dermatitis in Global Market
Table 2. Top Medications for Canine Atopic Dermatitis Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Medications for Canine Atopic Dermatitis Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Medications for Canine Atopic Dermatitis Revenue Share by Companies, 2019-2024
Table 5. Global Medications for Canine Atopic Dermatitis Sales by Companies, (K Units), 2019-2024
Table 6. Global Medications for Canine Atopic Dermatitis Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Medications for Canine Atopic Dermatitis Price (2019-2024) & (US$/Unit)
Table 8. Global Manufacturers Medications for Canine Atopic Dermatitis Product Type
Table 9. List of Global Tier 1 Medications for Canine Atopic Dermatitis Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Medications for Canine Atopic Dermatitis Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Global Medications for Canine Atopic Dermatitis Revenue (US$, Mn), 2019-2024
Table 13. By Type - Global Medications for Canine Atopic Dermatitis Revenue (US$, Mn), 2025-2030
Table 14. By Type - Global Medications for Canine Atopic Dermatitis Sales (K Units), 2019-2024
Table 15. By Type - Global Medications for Canine Atopic Dermatitis Sales (K Units), 2025-2030
Table 16. By Application ? Global Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Medications for Canine Atopic Dermatitis Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Medications for Canine Atopic Dermatitis Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Medications for Canine Atopic Dermatitis Sales (K Units), 2019-2024
Table 20. By Application - Global Medications for Canine Atopic Dermatitis Sales (K Units), 2025-2030
Table 21. By Region ? Global Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Medications for Canine Atopic Dermatitis Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Medications for Canine Atopic Dermatitis Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Medications for Canine Atopic Dermatitis Sales (K Units), 2019-2024
Table 25. By Region - Global Medications for Canine Atopic Dermatitis Sales (K Units), 2025-2030
Table 26. By Country - North America Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Medications for Canine Atopic Dermatitis Sales, (K Units), 2019-2024
Table 29. By Country - North America Medications for Canine Atopic Dermatitis Sales, (K Units), 2025-2030
Table 30. By Country - Europe Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Medications for Canine Atopic Dermatitis Sales, (K Units), 2019-2024
Table 33. By Country - Europe Medications for Canine Atopic Dermatitis Sales, (K Units), 2025-2030
Table 34. By Region - Asia Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Medications for Canine Atopic Dermatitis Sales, (K Units), 2019-2024
Table 37. By Region - Asia Medications for Canine Atopic Dermatitis Sales, (K Units), 2025-2030
Table 38. By Country - South America Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Medications for Canine Atopic Dermatitis Sales, (K Units), 2019-2024
Table 41. By Country - South America Medications for Canine Atopic Dermatitis Sales, (K Units), 2025-2030
Table 42. By Country - Middle East & Africa Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Medications for Canine Atopic Dermatitis Sales, (K Units), 2019-2024
Table 45. By Country - Middle East & Africa Medications for Canine Atopic Dermatitis Sales, (K Units), 2025-2030
Table 46. GlenHaven Company Summary
Table 47. GlenHaven Medications for Canine Atopic Dermatitis Product Offerings
Table 48. GlenHaven Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 49. GlenHaven Key News & Latest Developments
Table 50. DermaPet Company Summary
Table 51. DermaPet Medications for Canine Atopic Dermatitis Product Offerings
Table 52. DermaPet Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 53. DermaPet Key News & Latest Developments
Table 54. DVM Pharmaceuticals Company Summary
Table 55. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Product Offerings
Table 56. DVM Pharmaceuticals Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 57. DVM Pharmaceuticals Key News & Latest Developments
Table 58. Virbac Company Summary
Table 59. Virbac Medications for Canine Atopic Dermatitis Product Offerings
Table 60. Virbac Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 61. Virbac Key News & Latest Developments
Table 62. Enzo Life Sciences, Inc. Company Summary
Table 63. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Product Offerings
Table 64. Enzo Life Sciences, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 65. Enzo Life Sciences, Inc. Key News & Latest Developments
Table 66. Pfizer Animal Health Company Summary
Table 67. Pfizer Animal Health Medications for Canine Atopic Dermatitis Product Offerings
Table 68. Pfizer Animal Health Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 69. Pfizer Animal Health Key News & Latest Developments
Table 70. Novartis Animal Health, Inc. Company Summary
Table 71. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Product Offerings
Table 72. Novartis Animal Health, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 73. Novartis Animal Health, Inc. Key News & Latest Developments
Table 74. Eli Lilly and Company Company Summary
Table 75. Eli Lilly and Company Medications for Canine Atopic Dermatitis Product Offerings
Table 76. Eli Lilly and Company Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 77. Eli Lilly and Company Key News & Latest Developments
Table 78. Perrigo Company Summary
Table 79. Perrigo Medications for Canine Atopic Dermatitis Product Offerings
Table 80. Perrigo Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 81. Perrigo Key News & Latest Developments
Table 82. Merck & Company Company Summary
Table 83. Merck & Company Medications for Canine Atopic Dermatitis Product Offerings
Table 84. Merck & Company Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 85. Merck & Company Key News & Latest Developments
Table 86. Zoetis Inc. Company Summary
Table 87. Zoetis Inc. Medications for Canine Atopic Dermatitis Product Offerings
Table 88. Zoetis Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 89. Zoetis Inc. Key News & Latest Developments
Table 90. Toray Industries, Inc Company Summary
Table 91. Toray Industries, Inc Medications for Canine Atopic Dermatitis Product Offerings
Table 92. Toray Industries, Inc Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 93. Toray Industries, Inc Key News & Latest Developments
Table 94. Bayer Animal Health Company Summary
Table 95. Bayer Animal Health Medications for Canine Atopic Dermatitis Product Offerings
Table 96. Bayer Animal Health Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 97. Bayer Animal Health Key News & Latest Developments
Table 98. Putney, Inc. Company Summary
Table 99. Putney, Inc. Medications for Canine Atopic Dermatitis Product Offerings
Table 100. Putney, Inc. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 101. Putney, Inc. Key News & Latest Developments
Table 102. Dechra Company Summary
Table 103. Dechra Medications for Canine Atopic Dermatitis Product Offerings
Table 104. Dechra Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 105. Dechra Key News & Latest Developments
Table 106. Elanco Company Summary
Table 107. Elanco Medications for Canine Atopic Dermatitis Product Offerings
Table 108. Elanco Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 109. Elanco Key News & Latest Developments
Table 110. Kindred Biosciences Company Summary
Table 111. Kindred Biosciences Medications for Canine Atopic Dermatitis Product Offerings
Table 112. Kindred Biosciences Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 113. Kindred Biosciences Key News & Latest Developments
Table 114. Nippon Zenyaku Kogyo Co., Ltd. Company Summary
Table 115. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Product Offerings
Table 116. Nippon Zenyaku Kogyo Co., Ltd. Medications for Canine Atopic Dermatitis Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2019-2024)
Table 117. Nippon Zenyaku Kogyo Co., Ltd. Key News & Latest Developments
Table 118. Medications for Canine Atopic Dermatitis Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2024 (K Units)
Table 119. Global Medications for Canine Atopic Dermatitis Capacity Market Share of Key Manufacturers, 2021-2024
Table 120. Global Medications for Canine Atopic Dermatitis Production by Region, 2019-2024 (K Units)
Table 121. Global Medications for Canine Atopic Dermatitis Production by Region, 2025-2030 (K Units)
Table 122. Medications for Canine Atopic Dermatitis Market Opportunities & Trends in Global Market
Table 123. Medications for Canine Atopic Dermatitis Market Drivers in Global Market
Table 124. Medications for Canine Atopic Dermatitis Market Restraints in Global Market
Table 125. Medications for Canine Atopic Dermatitis Raw Materials
Table 126. Medications for Canine Atopic Dermatitis Raw Materials Suppliers in Global Market
Table 127. Typical Medications for Canine Atopic Dermatitis Downstream
Table 128. Medications for Canine Atopic Dermatitis Downstream Clients in Global Market
Table 129. Medications for Canine Atopic Dermatitis Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Medications for Canine Atopic Dermatitis Segment by Type in 2023
Figure 2. Medications for Canine Atopic Dermatitis Segment by Application in 2023
Figure 3. Global Medications for Canine Atopic Dermatitis Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Medications for Canine Atopic Dermatitis Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Medications for Canine Atopic Dermatitis Revenue, 2019-2030 (US$, Mn)
Figure 7. Medications for Canine Atopic Dermatitis Sales in Global Market: 2019-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Medications for Canine Atopic Dermatitis Revenue in 2023
Figure 9. By Type - Global Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Type - Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
Figure 11. By Type - Global Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
Figure 12. By Type - Global Medications for Canine Atopic Dermatitis Price (US$/Unit), 2019-2030
Figure 13. By Application - Global Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
Figure 15. By Application - Global Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
Figure 16. By Application - Global Medications for Canine Atopic Dermatitis Price (US$/Unit), 2019-2030
Figure 17. By Region - Global Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
Figure 20. By Region - Global Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
Figure 21. By Country - North America Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
Figure 22. By Country - North America Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
Figure 23. US Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
Figure 28. Germany Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 29. France Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
Figure 37. China Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 41. India Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
Figure 43. By Country - South America Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
Figure 44. Brazil Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Medications for Canine Atopic Dermatitis Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Medications for Canine Atopic Dermatitis Sales Market Share, 2019-2030
Figure 48. Turkey Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Medications for Canine Atopic Dermatitis Revenue, (US$, Mn), 2019-2030
Figure 52. Global Medications for Canine Atopic Dermatitis Production Capacity (K Units), 2019-2030
Figure 53. The Percentage of Production Medications for Canine Atopic Dermatitis by Region, 2023 VS 2030
Figure 54. Medications for Canine Atopic Dermatitis Industry Value Chain
Figure 55. Marketing Channels
